Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses
Clinical trial NCT00909688 · COMPLETED
Trial details
- NCT number
- NCT00909688
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-05
- Primary completion
- 2009-07-24
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.